MedPage Today on MSN
FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection
Semaglutide 7 mg and 14 mg tablets are now available for reducing the risk of cardiovascular death, heart attack, or stroke ...
As sniffles spread and citrus piles up, many of us reach for fizzing tablets, hoping to outpace winter’s first coughs. This ...
9d
Cycle Pharmaceuticals Launches Its First Oncology Product, PHYRAGO™ (dasatinib) Tablets, in the US
Cycle Pharmaceuticals announces the launch of PHYRAGO, its first oncology product in the US. PHYRAGO is launched in ...
In a recent regulatory update, the Central Drugs Standard Control Organisation (CDSCO) has formally approved the withdrawal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results